<?xml version="1.0" encoding="UTF-8"?>
<document id="29703754">
	<sentence id="s1" text="To explore the complementary behaviors of microtubule-based movement and Eg5, we also scored the effects of small-molecule inhibitors on admixtures of both motors, using both a microtubule (MT)-gliding assay and an assay for cancer cell viability.">
		<entity id="s1.e1" charOffset="42-68"
			type="GO" text="microtubule-based movement" ontology_id="GO_0007018"/>
		<entity id="s1.e2" charOffset="225-231"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We found that (i) microtubule-based movement motility differs significantly from Eg5; (ii) KIF15-IN-1 is a potent inhibitor of KIF15 motility; (iii) MT gliding powered by KIF15 and Eg5 only ceases when both motors are inhibited; and (iv) pairing KIF15-IN-1 with Eg5 inhibitors synergistically reduces cancer cell growth.">
		<entity id="s2.e1" charOffset="18-44"
			type="GO" text="microtubule-based movement" ontology_id="GO_0007018"/>
		<entity id="s2.e2" charOffset="301-307"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
</document>
